CLGM
IDXX icon

Capitolis Liquid Global Markets’s Idexx Laboratories IDXX Stock Holding History

Capitolis Liquid Global Markets’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,147
Closed -$7.39M – 357
2026
Q1 		$7.39M Buy
13,147
+10,516
+400% +$6.74M 0.05% 215
2025
Q4 		$1.78M Buy
+2,631
New +$1.79M 0.01% 287

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Capitolis Liquid Global Markets's IDXX Position: Q2 2026 in Review

Capitolis Liquid Global Markets sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 13,147 shares — an estimated $7.39M sold.

Capitolis Liquid Global Markets first reported a position in IDXX in Q4 2025 and held it in 2 quarters. The position peaked at $7.39M in Q1 2026. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Capitolis Liquid Global Markets reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Capitolis Liquid Global Markets sold 13,147 Idexx Laboratories shares in Q2 2026, an estimated $7.39M.
  • Capitolis Liquid Global Markets first reported a position in Idexx Laboratories in Q4 2025 and held it in 2 quarters.
  • Capitolis Liquid Global Markets's Idexx Laboratories position peaked at $7.39M in Q1 2026.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.